Alyasova AV - Search Results

1

Messenger RNA of FCGR3A and FCGR3B Genes as Monitoring Markers of Clear Cell Renal Adenocarcinoma (a Pilot Study).

Alyasova AV, Amoev ZV, Shkola OO, Novikov DV, Selivanova SG, Novikov VV. Alyasova AV, et al. Sovrem Tekhnologii Med. 2022;14(3):22-26. doi: 10.17691/stm2022.14.3.03. Epub 2022 May 28. Sovrem Tekhnologii Med. 2022. PMID: 37064811 Free PMC article.

2

Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4).

Motzer RJ, Alyasova A, Ye D, Karpenko A, Li H, Alekseev B, Xie L, Kurteva G, Kowalyszyn R, Karyakin O, Neron Y, Cosgriff T, Collins L, Brechenmacher T, Lin C, Morgan L, Yang L. Motzer RJ, et al. Ann Oncol. 2016 Mar;27(3):441-8. doi: 10.1093/annonc/mdv612. Epub 2015 Dec 17. Ann Oncol. 2016. PMID: 26681676 Free PMC article. Clinical Trial.

3

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.

Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Kopyltsov E, Méndez-Vidal MJ, Kozlov V, Alyasova A, Hong SH, Kapoor A, Alonso Gordoa T, Merchan JR, Winquist E, Maroto P, Goh JC, Kim M, Gurney H, Patel V, Peer A, Procopio G, Takagi T, Melichar B, Rolland F, De Giorgi U, Wong S, Bedke J, Schmidinger M, Dutcus CE, Smith AD, Dutta L, Mody K, Perini RF, Xing D, Choueiri TK; CLEAR Trial Investigators. Motzer R, et al. N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13. N Engl J Med. 2021. PMID: 33616314 Clinical Trial.

4

Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study.

Hesketh PJ, Rossi G, Rizzi G, Palmas M, Alyasova A, Bondarenko I, Lisyanskaya A, Gralla RJ. Hesketh PJ, et al. Ann Oncol. 2014 Jul;25(7):1340-1346. doi: 10.1093/annonc/mdu110. Epub 2014 Mar 7. Ann Oncol. 2014. PMID: 24608196 Free PMC article. Clinical Trial.

5

A case report of successful combined intra-arterial immunotherapy and cytokine genetic therapy treatment in a patient with recurrent glioblastoma.

Alyasova AV, Ben Ammar AM, Zarkua VT, Rerberg AG. Alyasova AV, et al. Chin Clin Oncol. 2024 Sep 6:cco-24-34. doi: 10.21037/cco-24-34. Online ahead of print. Chin Clin Oncol. 2024. PMID: 39260431 Free article.

6

Tumor M2-Pyruvate Kinase, Matrix Carbonic Anhydrase IX, and Metalloproteinase 9 - Novel Prognostic Markers of Renal Cell Carcinoma.

Amoev ZV, Alyasova AV, Gorshkova TN, Samsonova EI, Strokina EV, Kontorshchikova KN. Amoev ZV, et al. Among authors: alyasova av. Sovrem Tekhnologii Med. 2020;12(2):43-47. doi: 10.17691/stm2020.12.2.05. Sovrem Tekhnologii Med. 2020. PMID: 34513052 Free PMC article.

7

The level of Hydrogen Peroxide in HeLa Cells in an Ozonated Medium.

Kontorshchikova KN, Belova AS, Dudenkova VV, Orlova AG, Terent'ev IG, Tsybusov SN, Alyasova AV. Kontorshchikova KN, et al. Among authors: alyasova av. Bull Exp Biol Med. 2017 Aug;163(4):570-573. doi: 10.1007/s10517-017-3851-6. Epub 2017 Aug 29. Bull Exp Biol Med. 2017. PMID: 28853083

8

Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients.

Aapro M, Jordan K, Gralla RJ, Rizzi G, Rossi G, Palmas M, Alyasova AV, Lisyanskaya AS, Bošnjak SM, Hesketh PJ. Aapro M, et al. Among authors: alyasova av. J Geriatr Oncol. 2017 Jan;8(1):56-63. doi: 10.1016/j.jgo.2016.09.002. Epub 2016 Nov 23. J Geriatr Oncol. 2017. PMID: 27889278

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page